Literature DB >> 15196209

Understanding thymus-independent antigen-induced reduction of thymus-dependent immune responses.

Karin Lindroth1, Elena Fernández Mastache, Izaura Roos, Africa González Fernández, Carmen Fernández.   

Abstract

Deficiencies in immune responses against polysaccharides can have direct consequences for patients, and therefore, a better understanding of these immune reactions is crucial. We have studied the immune response against the polysaccharide dextran B512 (Dx). Administration of immunogenic doses of thymus-independent (TI) Dx reduces the immunoglobulin G1 response to later challenges with a thymus-dependent (TD) form of Dx. We investigated if this suppression is a general phenomenon caused not only by Dx but also by other TI antigens, and examined possible mechanisms contributing to this unresponsiveness. We show that clonal exhaustion is not involved in modulating subsequent responses, nor is signalling via FcgammaRIIB or other antibody mediated pathways. The reduced TD response is not an exclusive Dx phenomenon; it is also induced by TI antigen oxazolone (Ox). However, responses against the hapten dinitrophenyl (DNP) are not affected, indicating that the TI priming negative effect is not a general process. This may be explained by the restricted immune response to both Dx and Ox, in contrast to the unrestricted DNP response. Our conclusion from these experiments is that the underlying mechanism for the TI-induced reduction of latter TD responses is a property of the TI activation itself.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196209      PMCID: PMC1782500          DOI: 10.1111/j.1365-2567.2004.01894.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Activation of bovine B cells via surface immunoglobulin M cross-linking or CD40 ligation results in different B-cell phenotypes.

Authors:  K M Haas; D M Estes
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

Review 2.  Are polysaccharide antibody responses independent: the T cell enigma?

Authors:  P Lane
Journal:  Clin Exp Immunol       Date:  1996-07       Impact factor: 4.330

Review 3.  Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans.

Authors:  A Coutinho; G Möller; W Richter
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

4.  Immunogenicity of bacterial carbohydrates: cholera toxin modulates the immune response against dextran B512.

Authors:  E Sverremark; C Fernandez
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

5.  Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways.

Authors:  Y Z Cong; E Rabin; H H Wortis
Journal:  Int Immunol       Date:  1991-05       Impact factor: 4.823

6.  The response in old mice: positive and negative immune memory after priming in early age.

Authors:  M Sánchez; K Lindroth; E Sverremark; A González Fernández; C Fernández
Journal:  Int Immunol       Date:  2001-10       Impact factor: 4.823

7.  Unresponsiveness following immunization with the T-cell-independent antigen dextran B512. Can it be abrogated?

Authors:  E Sverremark; C Fernandez
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

8.  Germinal center formation following immunization with the polysaccharide dextran B512 is substantially increased by cholera toxin.

Authors:  E Sverremark; C Fernandez
Journal:  Int Immunol       Date:  1998-07       Impact factor: 4.823

9.  Genetic mechanisms for dominant VH gene expression. The VHB512 gene.

Authors:  C Fernandez
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

10.  B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes.

Authors:  H H Wortis; M Teutsch; M Higer; J Zheng; D C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more
  4 in total

1.  Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine.

Authors:  Frank M Orson; Roger D Rossen; Xiaoyun Shen; Angel Y Lopez; Yan Wu; Thomas R Kosten
Journal:  Am J Addict       Date:  2013-02-01

Review 2.  Vaccines against drug abuse.

Authors:  X Y Shen; F M Orson; T R Kosten
Journal:  Clin Pharmacol Ther       Date:  2011-11-30       Impact factor: 6.875

Review 3.  Immunotherapy for drug abuse.

Authors:  Xiaoyun Shen; Thomas R Kosten
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

Review 4.  Vaccines against stimulants: cocaine and MA.

Authors:  Thomas Kosten; Coreen Domingo; Frank Orson; Berma Kinsey
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.